# James L. Januzzi

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/james-l-januzzi/

## Facts

| Field | Value |
| --- | --- |
| Citations | 102,584 |
| Field | Heart Failure Treatment and Management |
| h-index | 136 |
| i10-index | 675 |
| Last Known Institution | Harvard University |
| OpenAlex ID | https://openalex.org/A5043064522 |
| ORCID iD | 0000-0002-8338-1798 |
| Works | 1,176 |

## Researcher papers

Showing 12 of 33.

- [2013 ACCF/AHA Guideline for the Management of Heart Failure](https://scholariq.org/papers/2013-accf-aha-guideline-for-the-management-of-heart-failure/)
- [Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure](https://scholariq.org/papers/cardiovascular-and-renal-outcomes-with-empagliflozin-in-heart-failure/)
- [Empagliflozin in Heart Failure with a Preserved Ejection Fraction](https://scholariq.org/papers/empagliflozin-in-heart-failure-with-a-preserved-ejection-fraction/)
- [2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary](https://scholariq.org/papers/2013-accf-aha-guideline-for-the-management-of-heart-failure-executive-summary/)
- [Third universal definition of myocardial infarction](https://scholariq.org/papers/third-universal-definition-of-myocardial-infarction-3/)
- [Third Universal Definition of Myocardial Infarction](https://scholariq.org/papers/third-universal-definition-of-myocardial-infarction/)
- [2013 ACCF/AHA Guideline for the Management of Heart Failure](https://scholariq.org/papers/2013-accf-aha-guideline-for-the-management-of-heart-failure-2/)
- [Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure](https://scholariq.org/papers/universal-definition-and-classification-of-heart-failure-a-report-of-the-heart/)
- [Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation](https://scholariq.org/papers/dual-antithrombotic-therapy-with-dabigatran-after-pci-in-atrial-fibrillation/)
- [The N-terminal Pro-BNP Investigation of Dyspnea in the Emergency department (PRIDE) study](https://scholariq.org/papers/the-n-terminal-pro-bnp-investigation-of-dyspnea-in-the-emergency-department/)
- [Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease](https://scholariq.org/papers/fibroblast-growth-factor-23-and-left-ventricular-hypertrophy-in-chronic-kidney/)
- [Assessment of Echocardiography and Biomarkers for the Extended Prediction of Cardiotoxicity in Patients Treated With Anthracyclines, Taxanes, and Trastuzumab](https://scholariq.org/papers/assessment-of-echocardiography-and-biomarkers-for-the-extended-prediction-of/)

## Researcher topics

- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Acute Myocardial Infarction Research](https://scholariq.org/topics/acute-myocardial-infarction-research/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Cardiac Imaging and Diagnostics](https://scholariq.org/topics/cardiac-imaging-and-diagnostics/)

## Researcher university

- [Harvard University](https://scholariq.org/institutions/harvard-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.